Evidence map›Paper›PMID 24785954›Full record

Trial reportAIDS (London, England)2014

Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy.

Todd Hulgan, Rebecca T Levinson, Mariana Gerschenson, Nittaya Phanuphak, Jintanat Ananworanich, Nipat Teeratakulpisarm, Tanate Jadwattanakul, Daniel E LiButti, Heidi Fink, Justin C McArthur and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Todd HulganaVanderbilt University, Nashville, Tennessee bUniversity of Hawaii, Honolulu, Hawaii, USA cSouth East Asia Research Collaboration with Hawaii dThai Red Cross AIDS Research Centre eHIV-NAT, Bangkok fQueen Savang Vadhana Memorial Hospital, Chonburi, Thailand gThe Johns Hopkins University, Baltimore, Maryland, USA.
Rebecca T Levinson
Mariana Gerschenson
Nittaya Phanuphak
Jintanat Ananworanich
Nipat Teeratakulpisarm
Tanate Jadwattanakul
Daniel E LiButti
Heidi Fink
Justin C McArthur
Gigi J Ebenezer
Peter Hauer
Deborah Murdock
Cecilia M Shikuma
David C Samuels
SEARCH 003 Study Team
Vanderbilt University · USJohns Hopkins University · USThai Red Cross Society · THUniversity of Hawaiʻi at Mānoa · USUniversity of Hawaii System · US

Funding

Therapeutic CoreP30MH075673 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Leah Helane Rubin · 2006 to 2026
$33.2M
WILLINGNESS OF PRIMARY CARE PHYSICIANS TO ADOPT HANDHELD COMPUTINGP20RR011091 · NCRR · UNIVERSITY OF HAWAII AT MANOA · PI ERDEM, GULIZ · 1995 to 2009
$16.5M
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and MechanismsR01NS063932 · NINDS · UNIVERSITY OF HAWAII AT MANOA · PI SHIKUMA, CECILIA M. · 2008 to 2012
$3.4M
Global HIV Drug Therapies and Mitochondrial Complications and MechanismsR01AI074554 · NIAID · UNIVERSITY OF HAWAII AT MANOA · PI GERSCHENSON, MARIANA · 2008 to 2012
$3.2M
Training Program on Genetic Variation and Human PhenotypesT32GM080178 · NIGMS · VANDERBILT UNIVERSITY · PI COX, NANCY J, SAMUELS, DAVID C · 2007 to 2021
$3.1M
HIV-sensory neuropathies:risk factors, immunopathologyR01NS044807 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MCARTHUR, JUSTIN C · 2002 to 2006
$2.6M
Predicting progression of NeuroAIDSR01NS049465 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MCARTHUR, JUSTIN C. · 2004 to 2007
$2.2M
NCRR NIH HHS P20 RR011091NCRR NIH HHS P20RR011091NIAID NIH HHS R01 AI074554NIAID NIH HHS R01AI074554NIGMS NIH HHS T32 GM080178NIMH NIH HHS 1P30MH075673NIMH NIH HHS P30 MH075673NINDS NIH HHS NS44807NINDS NIH HHS R01 NS044807NINDS NIH HHS R01 NS049465NINDS NIH HHS R01 NS063932NINDS NIH HHS R01NS063932
6 · The paper itself

Abstract

objectiveWe explored associations between mitochondrial DNA (mtDNA) haplogroups, epidermal nerve fiber density (ENFD), and HIV-associated sensory neuropathy (HIV-SN) in a randomized trial of Thai patients initiating antiretroviral therapy (ART).

designThe South East Asia Research Collaboration with Hawaii 003 study evaluated toxicity of nucleoside reverse transcriptase inhibitors (stavudine vs. zidovudine vs. tenofovir). We present secondary analyses of mtDNA haplogroups and ENFD changes.

methodsENFD, peripheral blood mononuclear cell mitochondrial complex I and IV, and 8-oxo-deoxyguanine (8-oxo-dG) were quantified. Peripheral blood mononuclear cell mtDNA sequences were obtained for haplogroup determination. Multivariate regression of ENFD change was performed.

resultsPaired ENFD was available from 118 patients. Median age, CD4 cell count, and height at entry were 34 years, 172 cells/μl, and 162 cm, respectively. Major haplogroups included M (42%), F (21%), and B (16%). Baseline ENFD, CD4 cell count, randomized ART, and biomarkers did not differ by haplogroup. Haplogroup B patients were older (P=0.02) at baseline, and had an increase in median ENFD (+1.5 vs. -2.9 fibers/mm; P=0.03) and 8-oxo-dG break frequency (+0.05 vs. 0.00; P=0.05) compared to other haplogroups. In a multivariate model, haplogroup B was associated with increased ENFD (β=3.5, P=0.009) at week 24, whereas older age (P=0.02), higher baseline CD4 cell count, (P=0.03), higher complex I level (P=0.03), and higher ENFD (P<0.001) at baseline were all associated with decreased ENFD. Three of the six HIV-SN cases were haplogroup B (P=0.05).

conclusionsThai persons belonging to mtDNA haplogroup B had increased ENFD and 8-oxo-dG on ART, and were more likely to develop HIV-SN. These results suggest that mtDNA variation influences early oxidative damage and ENFD changes.

Indexed as

Oxidative StressAdultAnimalsAsian PeopleEpidermisFemaleHaplotypesHIV InfectionsHumansMaleMitochondriaNerve FibersNervous System Diseases

Identifiers

PMID24785954
PMCPMC4427899
OpenAlexW2317632729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.